Liminatus Pharma Inc. (LIMN)
Market Closed
15 Oct, 08:00 PM
NASDAQ (NMS) NASDAQ (NMS) Primary $
3. 21
-0.04
-1.2308%
Pre Market
$
+0.19 +5.919% 3. 40
4.96M Market Cap
- P/E Ratio
- Div Yield
15,814 Volume
- Eps
$ 3.25
Previous Close Want to track LIMN and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Liminatus Pharma Inc. (LIMN) Statistics
Valuation metrics
Market Cap 4.96M
Enterprise value 3.48M
Trailing P/E (ttm) -0.16
Forward P/E -
PEG ratio -0
Price/Sales (ttm) -
Price/Book (mrq) 5.94
Enterprise Value/Revenue -
Enterprise Value/EBITDA -0.28
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 18.4K
Average volume (90 days) 11.07M
Price summary
52-Week low 3.21
52-Week high 141.5
Beta -
50-Day moving average 3.89
200-Day moving average 1.58
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:50
Last split Date 21 Aug 2026
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -3.68%
Return on equity 4.44%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -26.36
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 6.35
Total debt (mrq) -
Total Debt/Equity (mrq) 4.8
Current ratio (mrq) 1.12%
Book value per share (mrq) 0.63
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
